Iron polymaltose (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Iron polymaltose" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place

doi.org

  • Geisser, P. (2007). "Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience". Arzneimittelforschung. 57 (6A): 439–452. doi:10.1055/s-0031-1296693. PMID 17691594.
  • Geisser, P; Burckhardt, S. (4 January 2011). "The pharmacokinetics and pharmacodynamics of iron preparations". Pharmaceutics. 3 (1): 12–33. doi:10.3390/pharmaceutics3010012. PMC 3857035. PMID 24310424.
  • Toblli, JE; Brignoli, R (2007). "Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis". Arzneimittelforschung. 57 (6A): 431–438. doi:10.1055/s-0031-1296692. PMID 17691593.
  • Ortiz, R (November 2011). "Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study". Journal of Maternal-Fetal and Neonatal Medicine. 24 (11). et al.: 1347–52. doi:10.3109/14767058.2011.599080. PMID 21859366. S2CID 25666373.
  • Yasa, B (2011). "Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia". International Journal of Pediatrics. 2011. et al.: 524520. doi:10.1155/2011/524520. PMC 3206382. PMID 22121379.
  • Lundqvist, H; Sjöberg, F (2007). "Food interaction of oral uptake of iron / a clinical trial using 59Fe". Arzneimittelforschung. 57 (6A): 401–416. doi:10.1055/s-0031-1296689. PMID 17691590.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Geisser, P. (2007). "Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience". Arzneimittelforschung. 57 (6A): 439–452. doi:10.1055/s-0031-1296693. PMID 17691594.
  • Geisser, P; Burckhardt, S. (4 January 2011). "The pharmacokinetics and pharmacodynamics of iron preparations". Pharmaceutics. 3 (1): 12–33. doi:10.3390/pharmaceutics3010012. PMC 3857035. PMID 24310424.
  • Kaltwasser, JP; Werner, E; Niechzial, M (1987). "Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations". Arzneimittelforschung. 37 (1A): 122–129. PMID 3566867.
  • Toblli, JE; Brignoli, R (2007). "Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis". Arzneimittelforschung. 57 (6A): 431–438. doi:10.1055/s-0031-1296692. PMID 17691593.
  • Ortiz, R (November 2011). "Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study". Journal of Maternal-Fetal and Neonatal Medicine. 24 (11). et al.: 1347–52. doi:10.3109/14767058.2011.599080. PMID 21859366. S2CID 25666373.
  • Yasa, B (2011). "Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia". International Journal of Pediatrics. 2011. et al.: 524520. doi:10.1155/2011/524520. PMC 3206382. PMID 22121379.
  • Lundqvist, H; Sjöberg, F (2007). "Food interaction of oral uptake of iron / a clinical trial using 59Fe". Arzneimittelforschung. 57 (6A): 401–416. doi:10.1055/s-0031-1296689. PMID 17691590.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Ortiz, R (November 2011). "Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study". Journal of Maternal-Fetal and Neonatal Medicine. 24 (11). et al.: 1347–52. doi:10.3109/14767058.2011.599080. PMID 21859366. S2CID 25666373.